Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-096563
Filing Date
2023-04-10
Accepted
2023-04-10 16:30:30
Documents
15
Period of Report
2023-01-24
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d466536d8ka.htm   iXBRL 8-K/A 29938
2 EX-23.1 d466536dex231.htm EX-23.1 2068
3 EX-99.1 d466536dex991.htm EX-99.1 78978
4 EX-99.2 d466536dex992.htm EX-99.2 181424
  Complete submission text file 0001193125-23-096563.txt   455795

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cprx-20230124.xsd EX-101.SCH 2872
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20230124_lab.xml EX-101.LAB 18702
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20230124_pre.xml EX-101.PRE 11710
9 EXTRACTED XBRL INSTANCE DOCUMENT d466536d8ka_htm.xml XML 4560
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33057 | Film No.: 23811457
SIC: 2834 Pharmaceutical Preparations